NAVAN Technologies
Pre-clinicalNon-perturbative, gentle and precise delivery enables us to transport virtually all cargo types into virtually all primary cell types while preserving cell health and function. Efficacious dosage control, multiplexing and even cellular extraction/ sampling are core capabilities.
Founded
2018
Focus
OncologyCell Therapy
About
Non-perturbative, gentle and precise delivery enables us to transport virtually all cargo types into virtually all primary cell types while preserving cell health and function. Efficacious dosage control, multiplexing and even cellular extraction/ sampling are core capabilities.
Funding History
2Total raised: $20.2M
Series A$15MUndisclosedAug 15, 2023
Seed$5.2MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile